Demonstrate the activity of your cosmetic ingredients in synergy with or as protection against blue light
The main component of screens that we use everyday, are blue Light Emitting Diodes (LEDs). They emit blue light at a wavelength ranging between 400nm and 495nm, which can be harmful to the biological system. However, blue light has a more nuanced effect.
Studies have shown the benefits of blue light exposure. For instance, it is regularly used for wound healing purposes in-vivo by modulation of keratin gene expression.
It is common fact that blue light from prolonged exposition to screens is likely to create damages to the skin. Indeed, further studies have indicated that, similarly to UVA, blue light can also contribute to premature skin aging. This is due to its ability to penetrate the dermis and contribute to oxidative stress which contributes to the photoaging process.
GenSPECTRA is an original method designed by genel which explores the ambivalence of blue light effects
GENspectra methods
- Test the ability of your active ingredient to strengthen the wound healing properties of blue light.
- Validate the ability of your active ingredient to protect against the damages of blue light exposure.
Optimized process that guarantees fast and accurate results in as less as 2 months.
A combination of complementary functional and genomic tests that highlight the seboregulatory activity of the active ingredient.
Application of scientific techniques that address the current needs to develop ingredients for fighting acne.
